AI MARKET SCANNING

Syros Pharmaceuticals Inc

AVG HISTORICAL GAP -0.62%
MAX GAP RECORD -5.20%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $SYRS
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Oct 31, 2024 Earnings Release 2024-10-31 (BEFORE OPEN)
+0.80%
Jul 31, 2024 Earnings Release 2024-07-31 (BEFORE OPEN)
+3.67%
May 14, 2024 Earnings Release 2024-05-14 (BEFORE OPEN)
+1.19%
Mar 27, 2024 Earnings Release 2024-03-27 (BEFORE OPEN)
-4.80%
Nov 14, 2023 Earnings Release 2023-11-14 (BEFORE OPEN)
-5.20%
Aug 08, 2023 Earnings Release 2023-08-08 (BEFORE OPEN)
-3.80%
May 10, 2023 Earnings Release 2023-05-10 (BEFORE OPEN)
+0.00%
Mar 02, 2023 Earnings Release 2023-03-02 (BEFORE OPEN)
+3.83%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.3%
Bullish Gaps (3)
Bearish Gaps (3)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $SYRS

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗